| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918991 | Radiotherapy and Oncology | 2011 | 6 Pages |
Abstract
The prognosis of patients with ATC remains grim and our current results appear inferior to those reported previously by our institution. More accurate histologic diagnoses and patient selection in the present series compared to the prior one may be responsible in part. Better therapy is desperately needed for this aggressive disease.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Eric J. Sherman, Su Hsien Lim, Alan L. Ho, Ronald A. Ghossein, Matthew G. Fury, Ashok R. Shaha, Michael Rivera, Oscar Lin, Suzanne Wolden, Nancy Y. Lee, David G. Pfister,